[IOICORP] QoQ Annualized Quarter Result on 31-Dec-2018 [#2]

Stock
[IOICORP] IOI CORPORATION BHD
Announcement Date
20-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2019
Quarter
31-Dec-2018 [#2]
Profit Trend
QoQ- 17.98%
YoY- -64.5%
Quarter Report
Latest QR
Upcoming QR
IOICORP's Result
IOICORP's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 7,102,000 7,385,600 7,529,866 7,512,600 7,502,800 7,417,600 9,222,933 -15.97%
PBT 794,400 872,600 1,066,133 868,400 780,800 1,570,700 2,004,933 -46.02%
Tax -203,600 -255,000 -297,066 -194,800 -216,000 1,497,600 2,044,133 -
NP 590,800 617,600 769,066 673,600 564,800 3,068,300 4,049,066 -72.25%
-
NP to SH 596,000 631,700 780,133 678,600 575,200 3,060,500 4,032,933 -72.01%
-
Tax Rate 25.63% 29.22% 27.86% 22.43% 27.66% -95.35% -101.96% -
Total Cost 6,511,200 6,768,000 6,760,800 6,839,000 6,938,000 4,349,300 5,173,866 16.54%
-
Net Worth 9,489,812 9,301,273 9,238,353 9,175,303 8,986,725 9,175,222 9,111,655 2.74%
Dividend
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Div - 502,771 293,281 439,911 - 1,288,301 1,340,565 -
Div Payout % - 79.59% 37.59% 64.83% - 42.09% 33.24% -
Equity
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Net Worth 9,489,812 9,301,273 9,238,353 9,175,303 8,986,725 9,175,222 9,111,655 2.74%
NOSH 6,284,643 6,284,643 6,284,593 6,284,453 6,284,423 6,284,398 6,284,286 0.00%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 8.32% 8.36% 10.21% 8.97% 7.53% 41.37% 43.90% -
ROE 6.28% 6.79% 8.44% 7.40% 6.40% 33.36% 44.26% -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 113.01 117.52 119.81 119.54 119.39 118.03 146.77 -15.97%
EPS 9.48 10.05 12.41 10.80 9.16 48.70 64.17 -72.02%
DPS 0.00 8.00 4.67 7.00 0.00 20.50 21.33 -
NAPS 1.51 1.48 1.47 1.46 1.43 1.46 1.45 2.73%
Adjusted Per Share Value based on latest NOSH - 6,284,453
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 113.48 118.02 120.32 120.05 119.89 118.53 147.38 -15.97%
EPS 9.52 10.09 12.47 10.84 9.19 48.90 64.44 -72.02%
DPS 0.00 8.03 4.69 7.03 0.00 20.59 21.42 -
NAPS 1.5164 1.4863 1.4762 1.4661 1.436 1.4661 1.456 2.74%
Price Multiplier on Financial Quarter End Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 -
Price 4.43 4.25 4.46 4.45 4.54 4.54 4.79 -
P/RPS 3.92 3.62 3.72 3.72 3.80 3.85 3.26 13.06%
P/EPS 46.71 42.28 35.93 41.21 49.60 9.32 7.46 239.33%
EY 2.14 2.37 2.78 2.43 2.02 10.73 13.40 -70.53%
DY 0.00 1.88 1.05 1.57 0.00 4.52 4.45 -
P/NAPS 2.93 2.87 3.03 3.05 3.17 3.11 3.30 -7.61%
Price Multiplier on Announcement Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 26/11/19 15/08/19 21/05/19 20/02/19 12/11/18 17/08/18 16/05/18 -
Price 4.45 4.23 4.22 4.73 4.49 4.57 4.75 -
P/RPS 3.94 3.60 3.52 3.96 3.76 3.87 3.24 13.91%
P/EPS 46.92 42.08 34.00 43.80 49.06 9.38 7.40 242.18%
EY 2.13 2.38 2.94 2.28 2.04 10.66 13.51 -70.78%
DY 0.00 1.89 1.11 1.48 0.00 4.49 4.49 -
P/NAPS 2.95 2.86 2.87 3.24 3.14 3.13 3.28 -6.81%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment